Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease
about
A review of the medical treatment of primary sclerosing cholangitis in the 21st centuryInflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and managementCirrhosis and autoimmune liver disease: Current understandingFacing Terminal Ileitis: Going Beyond Crohn's DiseaseThe Changing Phenotype of Inflammatory Bowel DiseaseInflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features.Pathogenesis and clinical spectrum of primary sclerosing cholangitis.Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United KingdomMortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.The mucosa-associated microbiota of PSC patients is characterized by low diversity and low abundance of uncultured Clostridiales II.Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort.CCR9 Antagonists in the Treatment of Ulcerative Colitis.Interaction of gut microbiota with bile acid metabolism and its influence on disease states.Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity.Malignancies in Primary Sclerosing Cholangitis--A Continuing ThreatDuration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases.Recent insights in primary sclerosing cholangitis.Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.Inflammatory Bowel Disease with Primary Sclerosing Cholangitis: a Danish Population-based Cohort Study 1977-2011.Primary sclerosing cholangitis: a clinical update.Evolving strategies to reduce colectomy rates in primary sclerosing cholangitis-inflammatory bowel disease: clinical remission of corticosteroid refractory colitis post-liver transplant with vedolizumab.Recommendations on the use of MRI in PSC-A position statement from the International PSC study group.Autoimmune liver diseases and inflammatory bowel diseases in children: current issues and future perspectives.Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort.Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.Factors that Influence Health-Related Quality of Life in Patients with Primary Sclerosing Cholangitis.Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.Risk factors for primary sclerosing cholangitis.Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.Diagnosis, prognosis, and management of primary sclerosing cholangitis.Steroid-refractory ulcerative colitis and associated primary sclerosing cholangitis treated with infliximab.The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis.MMP-2 is a disease-modifying gene in primary sclerosing cholangitis.Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease.The 2016 diagnostic criteria for primary sclerosing cholangitis.
P2860
Q26771816-645DCEA5-9329-4E6D-8EA2-F0A7EE6882D3Q26994675-E2B110D9-7C3B-4829-A10A-C849432A032BQ27015831-1AF477E4-BAA8-4FDA-8328-31FDF8A2429BQ28070154-C9191E90-A392-41A9-B490-0AFD3B8326CDQ28077774-1A618E6A-5D54-4AB8-8D2D-5EFC5E580E76Q28354092-843F6BBA-3B4C-464A-A0C2-6C892F41E4C2Q30234950-FB186C85-2E08-487F-85E0-B2E1A43C2013Q33572623-F9473DC0-27B9-48BD-833C-358680745E02Q33818055-04707B3E-55D6-4324-A873-BE63F6995D1CQ34062402-8D440F72-BA60-4553-BC34-22EDA5361A53Q35535485-B43C7B1E-7A47-4802-B9B0-2B991F95C0D0Q35750365-B5E63C36-263A-4FCD-B291-FC58F78F0D01Q36118943-467080C7-00DF-48F0-A931-04E3A666E440Q36204422-913CF37A-FD76-400E-85DE-BC649C89180EQ36715515-B23B7357-E4D8-439B-B589-35D92F080989Q37082378-4E55B4AE-C529-4022-BA2E-072C41E8B4E9Q37265309-10337FEC-9745-4AA1-B18C-B0998ECC93CBQ37353271-86D2C068-00E5-4949-B312-88260F74D627Q38019989-FEAD8C42-37D2-441B-B6D4-FFD2DBB0FE56Q38356761-9549AE10-83FF-4769-ABAB-48FFD6CBD2B3Q38399155-60F050FD-19FA-4D75-A7E6-18C43DC5BA4CQ38485235-C451B7BC-3775-4806-AF7A-92C10AC47C34Q38608954-6F3FA5CD-21E3-49C1-B9B0-9D01DB580C2DQ38677506-803E7762-FC2A-4075-8885-59FC96445C1EQ38747656-546FD465-9B72-4FE5-B0BC-F1BC90633B02Q38919832-70CE4D26-3BF5-4BE3-A802-7B5EAEAE15CCQ39025709-45B79447-D118-46F2-83BB-CF92EE58366DQ39149647-84F7B4AD-98CC-43C4-82AB-9959603D4616Q39534358-B17D0794-C8FC-4D06-8EB7-5DAA80948F77Q40130719-723EB877-E711-4156-AC7E-A3DF2A604C08Q40418336-EC61A921-9BB7-46DE-8E28-113936D03B1EQ40832801-80846DCD-0289-48BE-94CE-EC58B9F07194Q40989271-B2FB03B3-9A9E-49D9-8E2B-7F18E855DCBFQ41087814-569AA98A-CEAA-4F66-B63C-BE178DE97F11Q41981735-24D21E8E-00CE-4E78-B05C-F92664B14AF4Q42253760-C0D377CA-BC56-48FF-890A-4E209E1A1F1AQ44505644-D46B2221-A876-4D54-91AC-277B7B77C5F2Q46214642-AF81AB81-8EC7-4529-B1BC-6AD1BAE1E4BFQ48151874-DA2D9717-8FA8-4C3A-AC4D-1B1D9E5547DBQ48179061-56917885-CAE4-4599-B1C8-3563ACB08CF3
P2860
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease
description
im Dezember 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2012
@uk
name
Primary sclerosing cholangitis ...... of inflammatory bowel disease
@en
Primary sclerosing cholangitis ...... of inflammatory bowel disease
@nl
type
label
Primary sclerosing cholangitis ...... of inflammatory bowel disease
@en
Primary sclerosing cholangitis ...... of inflammatory bowel disease
@nl
prefLabel
Primary sclerosing cholangitis ...... of inflammatory bowel disease
@en
Primary sclerosing cholangitis ...... of inflammatory bowel disease
@nl
P2093
P2860
P356
P1476
Primary sclerosing cholangitis ...... of inflammatory bowel disease
@en
P2093
Alexander C Poen
Ben J M Witteman
Cyriel Y Ponsioen
Hans A R E Tuynman
Joost P H Drenth
Karel J van Erpecum
Karin M J van Nieuwkerk
Kirsten Boonstra
Ulrich Beuers
P2860
P304
P356
10.1002/IBD.22938
P407
P577
2012-12-01T00:00:00Z